RespireRx Pharmaceuticals Inc (RSPI)
0.0033
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
RespireRx Pharmaceuticals Total Liabilities (Quarterly): 12.41M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 12.41M |
June 30, 2023 | 12.28M |
March 31, 2023 | 12.41M |
December 31, 2022 | 11.90M |
September 30, 2022 | 11.64M |
June 30, 2022 | 11.21M |
March 31, 2022 | 10.97M |
December 31, 2021 | 10.22M |
September 30, 2021 | 9.655M |
June 30, 2021 | 8.959M |
March 31, 2021 | 8.560M |
December 31, 2020 | 8.148M |
September 30, 2020 | 7.344M |
June 30, 2020 | 7.932M |
March 31, 2020 | 7.552M |
December 31, 2019 | 7.490M |
September 30, 2019 | 7.146M |
June 30, 2019 | 6.767M |
March 31, 2019 | 6.372M |
December 31, 2018 | 5.857M |
September 30, 2018 | 5.563M |
June 30, 2018 | 5.212M |
March 31, 2018 | 5.141M |
December 31, 2017 | 4.550M |
September 30, 2017 | 6.950M |
Date | Value |
---|---|
June 30, 2017 | 6.50M |
March 31, 2017 | 6.323M |
December 31, 2016 | 5.727M |
September 30, 2016 | 5.047M |
June 30, 2016 | 4.273M |
March 31, 2016 | 3.921M |
December 31, 2015 | 3.008M |
September 30, 2015 | 2.613M |
June 30, 2015 | 2.804M |
March 31, 2015 | 2.873M |
December 31, 2014 | 2.601M |
September 30, 2014 | 2.314M |
June 30, 2014 | 2.516M |
March 31, 2014 | 2.897M |
December 31, 2013 | 4.240M |
September 30, 2013 | 4.139M |
June 30, 2013 | 4.063M |
March 31, 2013 | 3.964M |
December 31, 2012 | 3.190M |
September 30, 2012 | 2.810M |
June 30, 2012 | 1.753M |
March 31, 2012 | 1.193M |
December 31, 2011 | 1.145M |
September 30, 2011 | 1.324M |
June 30, 2011 | 1.239M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.767M
Minimum
Jun 2019
12.41M
Maximum
Mar 2023
9.588M
Average
9.307M
Median
Total Liabilities (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 5.197M |
Palatin Technologies Inc | 9.827M |
iBio Inc | 25.29M |
Theriva Biologics Inc | 14.61M |
Oragenics Inc | 0.9087M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.1087M |
Shareholders Equity (Quarterly) | -12.30M |